Adage Capital Partners
GRCL

Adage Capital Partners’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Adage Capital Partners’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,350,000
Closed -$13.6M – 969
2023
Q4 		$13.6M Buy
1,350,000
+500,000
+59% +$5.02M 0.03% 532
2023
Q3 		$2.45M Buy
+850,000
New +$2.45M 0.01% 730